Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer
NCT07351565
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG:
Pitavastatin 1 mg daily or 4 mg daily
Sponsor
Chang Chen